Hela contaminant Antibody
Hela contaminant Antibody
 HeLa cells |
|||
| C0008001 | Addexbio | One Frozen vial | 546 EUR |
 HeLa Cell Extract |
|||
| 30R-AG012 | Fitzgerald | 100 ug | 418.8 EUR |
|
Description: Glutathiolated human epithelial carcinoma cell (HeLa) extract |
|||
) Human ; HeLa (#1) |
|||
| 02-723 | Sceti | 100ng | 481.2 EUR |
|
Description: The Human ; HeLa (#1) is available in Europe and for worldwide shipping via Gentaur. |
|||
 HeLa Nuclear Extract |
|||
| 1641-01 | Biovision | 222 EUR | |
HeLa Nuclear Extract |
|||
| 1641-1 | Biovision | 405.6 EUR | |
 HeLa Cell Slide |
|||
| 17-001 | ProSci | 1 pack | 216.6 EUR |
|
Description: HeLa S3 (cervix; adenocarcinoma) |
|||
) Chang Liver (HeLa) |
|||
| C0050007 | Addexbio | One Frozen vial | 651.6 EUR |
 HeLa Antigen Concentrate |
|||
| F813X | Cygnus Technologies | 1 ml | 632.4 EUR |
|
Description: HeLa Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 HeLa Membrane Lysate |
|||
| XBL-10439 | ProSci | 0.1 mg | 619.8 EUR |
|
Description: Hela (Human cervix Adenocarcinoma) cell membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The Hela (Human cervix Adenocarcinoma) cell was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Hela (cervix Adenocarcinoma) cell membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Hela (cervix Adenocarcinoma) cell membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
 Hela Nuclear Extract |
|||
| X12001 | EpiGentek | 1000 µg | Ask for price |
 HeLa/GFP Cell Line |
|||
| AKR-213 | Cell Biolabs | 1 vial | 686.4 EUR |
|
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
 HeLa/Cas9 Cell Line |
|||
| AKR-5111 | Cell Biolabs | 1 vial | 686.4 EUR |
 HeLa HCP ELISA Kit |
|||
| F810 | Cygnus Technologies | 1 kit (96 wells plate) | 1296 EUR |
|
Description: HeLa HCP ELISA Kit by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Anti-HeLa: HRP Conjugate |
|||
| F811 | Cygnus Technologies | 12 ml | 678 EUR |
|
Description: Anti-HeLa: HRP Conjugate by Cygnus Technologies is available in Europe via Gentaur. |
|||
 Hela-RFP stable cells |
|||
| SC031-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: RFP expression stable cell line in Hela cells with Puromycin marker. |
|||
) HeLa Nuclear Extract (DTT-free) |
|||
| 7947-01 | Biovision | 222 EUR | |
HeLa Nuclear Extract (DTT-free) |
|||
| 7947-1 | Biovision | 379.2 EUR | |
) HeLa Cell Lysate (Whole Cell) |
|||
| LYSATE0001 | Cusabio | 200ug | 180 EUR |
|
Description: This whole cell lysate is prepared from Hela cells using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Human Hela Whole Cell Lysate |
|||
| LYSATE0023 | BosterBio | 200ug | 180 EUR |
|
Description: This cell lysate is prepared from human hela using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
|||
 Anti-HeLa HCP, Affinity Purified |
|||
| HL59/73-AF | Cygnus Technologies | 1 mg | 2295.6 EUR |
|
Description: Anti-HeLa HCP, Affinity Purified by Cygnus Technologies is available in Europe via Gentaur. |
|||
 HeLa HCP Std. A-H |
|||
| F813 | Cygnus Technologies | 1 ml | 585.6 EUR |
|
Description: HeLa HCP Std. A-H by Cygnus Technologies is available in Europe via Gentaur. |
|||
) Hela-GFP stable cells (Blasticidin) |
|||
| SC034-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: GFP expression stable cell line in Hela cells with Blasticidin marker. |
|||
) Hela-GFP stable cells (Puromycin) |
|||
| SC034-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 930 EUR |
|
Description: GFP expression stable cell line in Hela cells with Puromycin marker. |
|||
 stable cells) Hela-TetR (Puro) stable cells |
|||
| SC035-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: tetracycline repressor expression Hela stable cell line with Puromycin marker |
|||
) HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
| NHELA-100 | Alpha Diagnostics | 100 ug | 196.8 EUR |
HeLa Nuclear Extract (Epithelioid carcinoma cells) |
|||
| NHELA-50 | Alpha Diagnostics | 50 ug | 153.6 EUR |
, Hela stable cells (Blasticidin)) Luciferase (firefly), Hela stable cells (Blasticidin) |
|||
| SC032-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: Luciferase (firefry) expression stable cell line in Hela cells with Blasticidin marker. |
|||
, Hela stable cells (Puromycin)) Luciferase (firefly), Hela stable cells (Puromycin) |
|||
| SC032-Puro | GenTarget | 2 x 106 cell/ml x 1ml | 1452 EUR |
|
Description: Luciferase (firefry) expression stable cell line in Hela cells with Puromycin marker. |
|||
 Inducible GFP Hela stable cell line |
|||
| SC036 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
|
Description: InducibleGFP expression stable cell line in Hela cells, with Neomycin and puromycin resitance |
|||
 Inducible RFP Hela stable cell line |
|||
| SC037 | GenTarget | 2 x 106 cell/ml x 1ml | 1800 EUR |
|
Description: Inducible RFP expression stable cell line in Hela with Blasticidin and Puromycin resistance |
|||
 stable cells) Hela-rtTA (GFP-Bsd) stable cells |
|||
| SC038-GB | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Blasticidin fusion dual marker |
|||
 stable cells) Hela-rtTA (GFP-Puro) stable cells |
|||
| SC038-GP | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with GFP-Puromycin fusion dual marker |
|||
 stable cells) Hela-rtTA (RFP-Bsd) stable cells |
|||
| SC038-RB | GenTarget | 2 x 106 cell/ml x 1ml | 1974 EUR |
|
Description: rtTA (reverse tetracycline Transcriptional Activator) expression Hela stable cell line with RFP-Blasticidin fusion dual marker |
|||
 Stable Cell Line) Hela / Cas9 (Bad) Stable Cell Line |
|||
| SC045-Cas9-Bsd | GenTarget | 2 x 106 cell/ml x 1ml | 1269.6 EUR |
|
Description: Cas9 expression stable cell line with Blasticidin resistance in Hela human cervical cancer cells. |
|||
 Rapid Test cards, 10/pk) TruStrip RDT Protein A (HCPs contaminant) Rapid Test cards, 10/pk |
|||
| 800-110-RDT-10 | Alpha Diagnostics | 1 Pk | 205.2 EUR |
 Rapid Test cards, 10/pk) TruStrip RDT Protein G (HCPs contaminant) Rapid Test cards, 10/pk |
|||
| 800-120-RDT-10 | Alpha Diagnostics | 1 Pk | 205.2 EUR |
 cDNA from Human Tumor Cell Line: Hela |
|||
| C1255811 | Biochain | 40 reactions | 451.2 EUR |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
) HeLa Cell Lysate (Human epithelial Cell Line) |
|||
| LF-R0001 | Abfrontier | 200 ul | 103.2 EUR |
|
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate |
|||
 lysate) Human HeLa-S3 (Cervix Epithelioid Carcinoma) lysate |
|||
| HCL-1201 | Alpha Diagnostics | 100ug | 285.6 EUR |
 Human HeLa Whole Cell Lysate, TNFa Stimulated |
|||
| HCL-2000 | Alpha Diagnostics | 100ug | 255.6 EUR |
 Cell Nuclear Extract) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract |
|||
| HCL-2008 | Alpha Diagnostics | 100ug | 270 EUR |
 Whole Cell Lysate) Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate |
|||
| HCL-2009 | Alpha Diagnostics | 1 mg | 628.8 EUR |
) Luciferase-2A-GFP, Hela stable cells (Blasticidin) |
|||
| SC032-GB | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
) Luciferase-2A-GFP, Hela stable cells (Neomycin) |
|||
| SC032-GN | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
) Luciferase-2A-GFP, Hela stable cells (Puromycin) |
|||
| SC032-GP | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and GFP co-expression stable cell line in Hela cells with Puromycin marker. |
|||
) Luciferase-2A-RFP, Hela stable cells (Blasticidin) |
|||
| SC032-RB | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Blasticidin marker. |
|||
) Luciferase-2A-RFP, Hela stable cells (Neomycin) |
|||
| SC032-RN | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Neomycin marker. |
|||
) Luciferase-2A-RFP, Hela stable cells (Puromycin) |
|||
| SC032-RP | GenTarget | 2 x 106 cell/ml x 1ml | 2148 EUR |
|
Description: Luciferase (firefry) and RFP co-expression stable cell line in Hela cells with Puromycin marker. |
|||
 Genomic DNA from Human Tumor Cell Line: Hela |
|||
| D1255811 | Biochain | 100 ug | 291.6 EUR |
|
Description: Can be used for various studies in the realm of gene expression, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
 Total Protein from Human Tumor Cell Line: Hela |
|||
| P1255811 | Biochain | 1 mg | 256.8 EUR |
|
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
) p300 protein WB +ve control (HeLa nuclear extract) |
|||
| P3001-C | Alpha Diagnostics | 100 ul | 343.2 EUR |
 Membrane Protein from Human Tumor Cell Line: Hela |
|||
| P3255811 | Biochain | 0.1 mg | 342 EUR |
|
Description: Can be used for various proteomics studies in both normal and pathological cases. It is an excellent control and suitable for educational purposes. This product is prepared from whole tissue homogenates and has undergone SDS-PAGE quality control analysis. The protein is stored in a buffer with protease inhibitor cocktail fo prevent degradation. |
|||
 Total RNA from Human Tumor Cell Line: Hela |
|||
| R1255811-50 | Biochain | 50 ug | 232.8 EUR |
|
Description: Can be used for various studies in the realm of gene expression and regulation, both normal and pathological. It is an excellent control and suitable for educational purposes. |
|||
) Recombinant Legionella Pneumophila helA Protein (aa 1-1052) |
|||
| VAng-Lsx3644-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: Legionella Pneumophila Protein HelA, recombinant protein. |
|||
, 96 tests) Carica papaya Papain ELISA kit (for measuring papain residue/contaminant in therapeutics), 96 tests |
|||
| 800-160-CPP | Alpha Diagnostics | 1 Kit | 927.6 EUR |
) NHEJ Based HeLa Requires I-Sce1 Transfection (50ug DNA) |
|||
| DR5001-HNHela-Sce | TopoGen | 50ug DNA | 3174 EUR |
) NHEJ Based HeLa Requires I-Sce1 Transfection (100ug DNA) |
|||
| DR5001-HNHela-Sce2 | TopoGen | 100ug DNA | 3486 EUR |
) NHEJ Based HeLa Requires I-Sce1 Transfection (250ug DNA) |
|||
| DR5001-HNHela-Sce3 | TopoGen | 250ug DNA | 4110 EUR |
) H2O2 stimulated HeLa Cell Lysate (Human epithelial cell line) |
|||
| LF-R0002 | Abfrontier | Each 100 ul | 145.2 EUR |
|
Description: HeLa (Human epithelial carcinoma cell line) Whole Cell Lysate - H2O2 stimulated |
|||
 Cell Nuclear Extract - Doxorubicin Stimulated) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Doxorubicin Stimulated |
|||
| HCL-2004 | Alpha Diagnostics | 100ug | 270 EUR |
 Cell Nuclear Extract - Etoposide Stimulated) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Etoposide Stimulated |
|||
| HCL-2005 | Alpha Diagnostics | 100ug | 270 EUR |
 Cell Nuclear Extract - Nocodozole Stimulated) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - Nocodozole Stimulated |
|||
| HCL-2006 | Alpha Diagnostics | 100ug | 270 EUR |
 Cell Nuclear Extract - TNFa Stimulated) Human HeLa (Cervix Adenocarcinoma) Cell Nuclear Extract - TNFa Stimulated |
|||
| HCL-2007 | Alpha Diagnostics | 100ug | 270 EUR |
 Whole Cell Lysate - Doxorubicin Stimulated) Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Doxorubicin Stimulated |
|||
| HCL-2010 | Alpha Diagnostics | 100ug | 255.6 EUR |
 Whole Cell Lysate - Etoposide Stimulated) Human HeLa (Cervix Adenocarcinoma) Whole Cell Lysate - Etoposide Stimulated |
|||
| HCL-2011 | Alpha Diagnostics | 100ug | 255.6 EUR |
) HR based Kit in HeLa Requiring CRISPR Transfection (50ug DNA) |
|||
| DR3000-HRHeLa-CPR | TopoGen | 50ug DNA | 3298.8 EUR |
) HR based Kit in HeLa Requiring CRISPR Transfection (100ug DNA) |
|||
| DR3000-HRHeLa-CPR2 | TopoGen | 100ug DNA | 3610.8 EUR |
) HR based Kit in HeLa Requiring CRISPR Transfection (250ug DNA) |
|||
| DR3000-HRHeLa-CPR3 | TopoGen | 250ug DNA | 4234.8 EUR |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (50ug DNA) |
|||
| DR3000-HRHeLa-Sce | TopoGen | 50ug DNA | 3174 EUR |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (100ug DNA) |
|||
| DR3000-HRHeLa-Sce2 | TopoGen | 100ug DNA | 3486 EUR |
) HR based Kit in HeLa Requiring I-Sce1 Transfection (250ug DNA) |
|||
| DR3000-HRHeLa-Sce3 | TopoGen | 250ug DNA | 4110 EUR |
 protein control for WB) Human Glyceraldehyde-3-Phosphate Dehydrogenase G3PDH/GAPDH (HeLa) protein control for WB |
|||
| G3PDH13-C | Alpha Diagnostics | 100 ul | 343.2 EUR |